BASF boosts ingredient release
active ingredients more quickly, particularly when it comes to
small tablets.
With Kollidon CL-F and Kollidon CL-SF, BASF is now launching two new tablet disintegrants that are particularly suitable for the manufacture of very small tablets, an important consideration since smaller and smaller tablets make it easier to take medication.
The new disintegrants ensure that the tablets disintegrate quickly and thereby increase the bioavailability of the active pharmaceutical ingredients, which can be released even more rapidly.
This is achieved by means of the special swelling properties of the popcorn polymers Kollidon CL-F and Kollidon CL-SF.
Both products are characterized by a small particle size allowing uniform distribution, even in small tablets.
The consistency of tablets also plays an important role for patients who take medication and this is particularly relevent in the case of fast-disintegrating tablets, as it is essential that all the ingredients feel good in the mouth. Kollidon CL-SF especially contributes to a pleasant feeling in the mouth.
The new, highly functional tablet disintegrants are additions to BASF's existing Kollidon CL range, meaning BASF can offer the choice of specific disintegrants for their particular application.
Kollidon CL-F and Kollidon CL-SF are exhibited this week for the first time at the conference of the Controlled Release Society in Vienna. In-PharmaTechnologist.com is there and will be bringing you all the big stories from the conference.
